Julie Iwashita
Hoofd Techniek/Wetenschap/O&O bij CONTINEUM THERAPEUTICS, INC.
Oorsprong van het eerstegraads netwerk van Julie Iwashita
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 26 | |
Proteolix, Inc.
 Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA
14
| Extinct | Pharmaceuticals: Major | 14 |
Cirius Therapeutics, Inc.
 Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA.
14
| Holding Company | Biotechnology | 14 |
Sorbent Therapeutics, Inc.
 Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA.
9
| Private Company | Pharmaceuticals: Major | 9 |
Laguna Pharmaceuticals, Inc.
 Laguna Pharmaceuticals, Inc. BiotechnologyHealth Technology Laguna Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. Its lead product, Vanoxerine is a therapeutic candidate being developed for treatment of atrial fibrillation and atrial flutter. The firm’s product is a potential pharmaceutical option to rapidly terminate atrial fibrillation in both hospital and home settings. The company was founded in 2006 by Arthur M. Brown and Howard C. Dittrich and is headquartered in Cleveland, OH.
7
| Extinct | Biotechnology | 7 |
| Public Company | Biotechnology | 6 | |
MAP Pharmaceuticals LLC
 MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA.
4
| Subsidiary | Medical Specialties | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Julie Iwashita via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ALZA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal Chief Operating Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Treasurer General Counsel Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing General Counsel Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Consultant / Advisor Private Equity Investor | |
| RIGEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| HOSPIRA, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Founder Investor Relations Contact Director of Finance/CFO | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder | |
NovaCardia, Inc.
 NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Founder Corporate Officer/Principal Corporate Officer/Principal | |
| KYTHERA BIOPHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder | |
| ANAPTYSBIO, INC. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Chairman Chairman Director/Board Member | |
Calistoga Pharmaceuticals, Inc.
 Calistoga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calistoga Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The company was founded by Michael W. Gallatin, Roger Ulrich and Neil Giese in March 2006 and is headquartered in Tumwater, WA. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
Metabolic Solutions Development Co. LLC
 Metabolic Solutions Development Co. LLC Pharmaceuticals: GenericHealth Technology Metabolic Solutions Development Co. LLC operates as a drug discovery and development company. It develops novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company was founded by Jerry Colca and Rolf Kletzien in 2006 and is headquartered in Kalamazoo, MI. | Pharmaceuticals: Generic | Corporate Officer/Principal Director/Board Member Director/Board Member Founder | |
Semnur Pharmaceuticals, Inc.
 Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree | |
| XENOPORT, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Secretary | |
| University of California, Los Angeles | College/University | Undergraduate Degree Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Doctorate Degree Masters Business Admin | |
| State University of New York at Buffalo | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| University of California, Berkeley | College/University | Corporate Officer/Principal Masters Business Admin Corporate Officer/Principal Graduate Degree Undergraduate Degree | |
| University of California San Diego | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Illinois | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| University of Michigan | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Corporate Officer/Principal | |
| Grand Valley State University Foundation | Director/Board Member Director/Board Member | ||
Van Andel Institute
 Van Andel Institute Miscellaneous Commercial ServicesCommercial Services Van Andel Institute provides biomedical research and education services. Its services include antibody production, spectral karyotyping, immunostaining and mouse modeling, animal imaging, computational biology, flow cytometry, germline modification and cytogenetics, mass spectrometry and proteomics, microarray technology, sequencing, vivarium, xenotransplantation and michigan animal consortium, as well as analytical, cellular and molecular microscopy services. The company was founded by Jay van Andel and Betty Van Andel in 1996 and is headquartered in Grand Rapids, MI. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
| RELYPSA INC | Pharmaceuticals: Major | Chairman Founder Director/Board Member Investor Relations Contact | |
| PROTAGONIST THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Director/Board Member Corporate Officer/Principal | |
| CALITHERA BIOSCIENCES, INC. | Biotechnology | Corporate Officer/Principal Director of Finance/CFO Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Founder Founder Corporate Officer/Principal | |
| DERMIRA, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Human Resources Officer | |
| LOXO ONCOLOGY INC | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| UCLA Anderson School of Management | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Hawkeye Therapeutics, Inc.
 Hawkeye Therapeutics, Inc. BiotechnologyHealth Technology Hawkeye Therapeutics, Inc. licenses and develops assets from pharmaceutical companies. The company is headquartered in San Diego, CA. | Biotechnology | Founder Chief Executive Officer Founder | |
Mavupharma, Inc.
 Mavupharma, Inc. Pharmaceuticals: MajorHealth Technology Mavupharma, Inc. engages development of non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease. The company was founded by W. Michael Gallatin, Brian K. Farmer, and Robert F. Baltera, Jr. and is headquartered in Kirkland, WA. | Pharmaceuticals: Major | Director/Board Member Founder Founder | |
| ARAVIVE, INC. | Biotechnology | Director/Board Member Chief Executive Officer Director of Finance/CFO | |
| Tentarix Biotherapeutics, Inc. | Chief Executive Officer Director/Board Member | ||
Radionetics Oncology, Inc.
 Radionetics Oncology, Inc. Pharmaceuticals: MajorHealth Technology Radionetics Oncology, Inc. is a clinical stage radiopharmaceutical company based in Menlo Park, CA. Radionetics Oncology, Inc. focuses on the discovery and development of novel radiotherapeutics for the treatment of various oncology indications. Radionetics Oncology spun out of Crinetics Pharmaceuticals and is supported by Frazier Life Sciences, 5AM Ventures, DCVC Bio, Crinetics Pharmaceuticals, and GordonMD Investments. The company is advancing a pipeline of small molecule radioligands that target G-protein coupled receptors to treat a wide range of cancers, including adrenocortical carcinoma, breast cancer, and lung cancer. The company's platform technology uses nonpeptide, small molecule targeting to deliver therapeutic radioisotopes selectively to tumors expressing peptide receptors. The company's pipeline consists of multiple lead drug candidates, and they are conducting additional drug discovery efforts in collaboration with Crinetics Pharmaceuticals. The market for radiopharmaceuticals is expected to rise to $12.6 billion by 2027. The company was founded by Scott R. Struthers, and Paul A. Grayson has been the CEO since 2024. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| ZOSANO PHARMA CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 50 |
Sectoraal
| Health Technology | 34 |
| Consumer Services | 11 |
| Commercial Services | 3 |
| Finance | 2 |
| Retail Trade | 2 |
Operationeel
| Director/Board Member | 496 |
| Corporate Officer/Principal | 210 |
| Independent Dir/Board Member | 145 |
| Chief Executive Officer | 90 |
| Chairman | 86 |
Sterkste connecties
| Insiders | |
|---|---|
| James Topper | 52 |
| John P. Walker | 39 |
| Steven Elms | 37 |
| Elizabeth Czerepak | 32 |
| Jim Woody | 31 |
| Carl Goldfischer | 31 |
| Ted Love | 31 |
| Jay Shepard | 30 |
| Jerel Davis | 29 |
| Mike J. Jandernoa | 28 |
| Dennis Fenton | 28 |
| Lori Kunkel | 27 |
| Nilesh Kumar | 26 |
| Dan Spiegelman | 25 |
| Paul Hastings | 25 |
- Beurs
- Insiders
- Julie Iwashita
- Bedrijfsconnecties
